CD274 and neoplasm: TAMs can inhibit the recruitment and activation of T cells, regulate PD-L1 expression on tumor cells, and usually form a tumor suppressive microenvironment to affect the therapeutic efficacy of PD-1/PD-L1 inhibitors.